Impact of HSV-2 episodic therapy on HIV-1 and HSV-2 genital shedding and ulcer healing among women in Ghana and the Central African Republic: Randomised double-blind placebo-controlled trial (ANRS 1212 study)
block.GIF (810 bytes)
Library

 
Download Acrobat Reader

To view some of the files in this section, you will require a version of Adobe Acrobat. This is free to download and is available on the Adobe Acrobat website.

Download PowerPoint Viewer

To view the PowerPoint presentations you will require Microsoft PowerPoint. You can download the latest PowerPoint viewer free from the Microsoft website.

You are welcome to download, view and use many of the slides contained in these presentations, however the original presenter and IHMF® must be suitably acknowledged for any use, for example in oral presentations or written material. Please also be aware that some slides contain graphs, illustrations or other content that may not be the copyright of the presenter or the IHMF® and permission ot use such material will need to be obtained from the copyright owner prior to use. Some of the slide presentations from the 13th IHMF® Annual Meeting are subject to 'restricted use' and the presentations to which this applies are labelled with the notice 'Restricted Use - please contact the presenter prior to any use of the content of this presentation'. These 'restricted use' presentations may only be viewed online or downloaded to view, and the original presenter must be contacted prior to any use.

If you are in any doubt about your use of this material, please contact the IHMF Secretariat.

Impact of HSV-2 episodic therapy on HIV-1 and HSV-2 genital shedding and ulcer healing among women in Ghana and the Central African Republic: Randomised double-blind placebo-controlled trial (ANRS 1212 study)

Presenter: Jérôme LeGoff. Virology Unit and U743, HEGP, Inserm, Paris, France.

 

Objectives: There is conflicting evidence linking HSV-2 infection to HIV-1 transmissibility.We assessed HSV-2–HIV associations among women with genital ulcer disease (GUD) at baseline of a randomized placebo-controlled trial of episodic aciclovir treatment conducted in Ghana and Central African Republic.

 

Methods: Blood samples were analysed for HSV-2, syphilis and HIV serologies, CD4 lymphocyte count and plasma HIV-1 RNA load. GUD aetiology and lesional HIV-1 RNA were determined by polymerase chain reaction (PCR) from ulcer swabs. HIV-1 and HSV-2 cervico-vaginal (CV) shedding were assessed in CV lavages (CVL) by real-time PCR. CVL with positive Y-chromosome PCR were excluded. Women were defined as HIV-1 or HSV-2-infected if virus (HIV-1 RNA or HSV-2 DNA) was detected in a lesion or CVL, or they were seropositive.

 

Results: 388/441 (88%) women had Y-PCR-negative CVL, of whom 47% were HIV-1 infected and 79% were HSV-2-infected. 188 (50%) women had an HSV-2 ulcer, a further 14 women had detectable CV HSV-2 DNA only, and 177 women had no lesional or CV HSV-2 DNA. Among HIV-1-infected women, CV HIV-1 RNA was more frequently detected in women with HSV-2 ulcers (68%) or CV HSV-2 DNA only (73%) compared with women without HSV-2 infection (43%) (P=0.004). Similarly, CV HIV-1 RNA loads were higher among women with HSV-2 ulcers or CV HSV-2 DNA (3.13 and 3.17 log10 copies/mL) compared with women without HSV-2 genital infection (1.2 log10 copies/mL) (P=0.002). 180 women were co-infected with HIV-1 and HSV-2. Among these, median CV HIV-1 RNA load was significantly higher among women with detectable CV HSV-2 DNA than those without (3.43 vs 1.2 log10 copies/mL; P<0.001). Similarly, plasma HIV-1 RNA load was higher among women with CV HSV-2 DNA (median 5.13 vs 4.64 log10 copies/mL; P=0.03). Detectable CV HIV-1 RNA was also associated with lower CD4 counts, increased plasma HIV-1 RNA and presence of lesional HIV-1 RNA. There was significant correlation in the quantities of CV HIV-1 RNA and CV HSV-2 DNA detected among co-infected women (Spearman’s correlation 0.35, P<0.001), and after adjusting for CD4 count and plasma HIV-1 RNA load.

 

Conclusions: HSV-2 lesional and genital shedding was associated with increased genital HIV-1 replication in the population of HIV-1- and HSV-2-infected women with GUD. These findings provide biological plausibility for the role of HSV-2 as a co factor of sexual transmission of HIV-1.

 

View

Download



 

- - - -
The IHMF® is a registered trademark of PAREXEL MMS
© 1998-2007 Cambridge Medical Publications. All rights reserved.
Last Updated : 29/03/2007 13:14:40